Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy

Menopause

Volumn 21, Issue 5, 2014, Pages 450-458

  Brotman, Rebecca M ^a   Shardell, Michelle D ^a   Gajer, Pawel ^a   Fadrosh, Doug ^a   Chang, Kathryn ^b   Silver, Michelle I ^b   Viscidi, Raphael P ^a   Burke, Anne E ^c   Ravel, Jacques ^a   Gravitt, Patti E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

16S ribosomal RNA gene analysis; Menopause; Vaginal atrophy; Vaginal microbiota

Indexed keywords

BACTERIAL RNA; RNA 16S;

ADULT; ARTICLE; ATROPHIC VAGINITIS; BACTERIAL GENE; CLIMACTERIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; MAJOR CLINICAL STUDY; MENOPAUSE; MICROBIAL COMMUNITY; NONHUMAN; POPULATION ABUNDANCE; POSTMENOPAUSE; PREMENOPAUSE; PREVOTELLA; PYROSEQUENCING; RNA ANALYSIS; SPECIES COMPOSITION; STREPTOCOCCUS; VAGINA ATROPHY; VAGINA FLORA; VAGINAL DRYNESS; ATROPHY; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; VAGINA; VULVA;

ADULT; ATROPHY; FEMALE; HUMANS; LACTOBACILLUS; MENOPAUSE; MICROBIOTA; MIDDLE AGED; MULTIVARIATE ANALYSIS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; VAGINA; VULVA;

EID: 84899908581     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e3182a4690b     Document Type: Article

References (66)

1. Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. MayoClin Proc 2010;85:87-94.
2. Simon JA, Reape KZ. Understanding the menopausal experiences ofprofessional women. Menopause 2009;16:73-76.
3. Sturdee DW, Panay N. Recommendations for the management of postmenopausalvaginal atrophy. Climacteric 2010;13:509-522.
4. Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes(VIVA)Vresults from an international survey. Climacteric 2012;15:36-44.
5. Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophyYrelatedsexual dysfunction in postmenopausal women: an up-to-date review [Review].Menopause 2012;19:109-117.
6. The North American Menopause Society. The 2012 hormone therapyposition statement of: The North American Menopause Society. Menopause2012;19:257-271.
7. Kingsberg SA, Krychman ML. Resistance and barriers to local estrogentherapy in women with atrophic vaginitis. J Sex Med 2013;10:1567-1574.
8. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophyin postmenopausal women [Meta-Analysis Review]. Cochrane DatabaseSyst Rev 2006;CD001500.
9. Nyirjesy P. Postmenopausal vaginitis. Curr Infect Dis Rep 2007;9:480-484.
10. Castelo-Branco C, Cancelo MJ\, Villero J, Nohales F, Juliá MD. Managementof post-menopausal vaginal atrophy and atrophic vaginitis.Maturitas 2005;52(suppl 1):S46-S52.
11. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of thevaginal microbiota measured by Gram stain analysis. Sex Transm Infect2010;86:297-302.
12. Gorbach PM, Weiss RE, Fuchs E, et al. The slippery slope: lubricant useand rectal sexually transmitted infections: a newly identified risk. SexTransm Dis 2012;39:59-64.
13. Adriaens E, Remon JP. Mucosal irritation potential of personal lubricantsrelates to product osmolality as detected by the slug mucosal irritationassay. Sex Transm Dis 2008;35:512-516.
14. Wolf LK. Studies raise questions about safety of personal lubricants.Chem Eng News 2012;90:46-47. Available at: http://cen.acs.org/articles/90/i50/ Studies-Raise-Questions-Safety-Personal.html2012. AccessedDecember 10, 2012.
15. Hansen KA, Eyster KM. What happened to WHI: menopausal hormonaltherapy in 2012. Clin Obstet Gynecol 2012;55:706-712.
16. Hummelen R, Macklaim JM, Bisanz JE, et al. Vaginal microbiome andepithelial gene array in post-menopausal women with moderate to severedryness. PLoS ONE 2011;6:e26602.
17. Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, doubleblind,placebo-controlled study of oral lactobacilli to improve the vaginalflora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol2008;141:54-57.
18. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associatedwith increased risk of female-to-male HIV-1 transmission: a prospectivecohort analysis among African couples. PLoS Med 2012;9:e1001251.
19. Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosisassessed by Gram stain and diminished colonization resistance to incidentgonococcal, chlamydial, and trichomonal genital infection. J Infect Dis2010;202:1907-1915.
20. Martin DH. The microbiota of the vagina and its influence on women'shealth and disease. Am J Med Sci 2012;343:2-9.
21. Cruickshank R. The conversion of the glycogen of the vagina into lacticacid. J Pathol Bacteriol 1934;39:213-219.
22. Bomar L, Maltz M, Colston S, Graf J. Directed culturing of microorganismsusing metatranscriptomics. mBio 2011;2:e00012-e00011.
23. Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and insitu detection of individual microbial cells without cultivation. MicrobiolRev 1995;59:143-169.
24. Bakken LR. Separation and purification of bacteria from soil. Appl EnvironMicrobiol 1985;49:1482-1487.
25. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. GenomeRes 2001;11:3-11.
26. Srinivasan S, Hoffman NG, Morgan MT, et al. Bacterial communities inwomen with bacterial vaginosis: high resolution phylogenetic analysesreveal relationships of microbiota to clinical criteria. PLoS ONE 2012;7:e37818.
27. Brotman R, Gajer P, Sakamoto J, et al. Temporal dynamics of vaginalbacterial communities. International Society for Sexually TransmittedDisease Research, July 10 to 13, 2011, Quebec City, Canada.
28. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductiveagewomen. Proc Natl Acad Sci USA 2011;108(suppl 1):4680-4687.
29. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, MartinDH. Association of Atopobium vaginae, a recently described metronidazoleresistant anaerobe, with bacterial vaginosis. BMC Infect Dis2004;4:5.
30. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification ofbacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-1911.
31. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of humanvaginal bacteria and relationship with bacterial vaginosis. PLoS ONE2010;5:e10197.
32. Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the humanvaginal microbiota. Sci Transl Med 2012;4:132ra52.
33. Gravitt PE, Silver MI, Marks M, Chang K, Burke AE, Visicidi R. Acohort effect of the sexual revolution may be masking an increase inhuman papillomavirus detection at menopause in the United States.J Infect Dis 2013;207:272-280.
34. Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE.Contributions of recent and past sexual partnerships on incident humanpapillomavirus detection: acquisition and reactivation in older women.Cancer Res 2012;72:6183-6190.
35. Rositch AF, Silver MI, Burke A, et al. The correlation between humanpapillomavirus positivity and abnormal cervical cytology result differsby age among perimenopausal women. J Low Genit Tract Dis 2013;17:38-47.
36. Marks MA, Viscidi RP, Chang K, et al. Differences in the concentrationand correlation of cervical immune markers among HPV positive andnegative perimenopausal women. Cytokine 2011;56:798-803.
37. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages ofReproductive Aging Workshop (STRAW) Park City, Utah, July, 2001.Menopause. 2001;8:402-407.
38. McKenna P, Hoffmann C, Minkah N, et al. The macaque gut microbiomein health, lentiviral infection, and chronic enterocolitis. PLoS Pathog2008;4:e20.39.
39. Edgar RC. Search and clustering orders of magnitude faster than BLAST.Bioinformatics 2010;26:2460-2461.
40. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improvessensitivity and speed of chimera detection. Bioinformatics 2011;27:2194-2200.
41. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier forrapid assignment of rRNA sequences into the new bacterial taxonomy.Appl Environ Microbiol 2007;73:5261-5267.
42. Gelman A, Hill J. Data Analysis Using Regression and Multilevel/ Hierarchical Models. Cambridge, UK: Cambridge University Press, 2007.
43. Imai K, King G, Lau O. Toward a common framework for statisticalanalysis and development. J Comput Graph Stat 2008;17:892-913.
44. Geweke JF. Evaluating the accuracy of sampling-based approaches to thecalculation of posterior moments. Federal Reserve Bank of Minneapolis,Research Department Staff Report 148. Minneapolis,MN: Federal Reserve Bankof Minneapolis, 1991. Available at: http://www.minneapolisfed.org/ research/sr/sr148.pdf.
45. Heidelberger P, Welch PD. Simulation run length control in the presenceof an initial transient. Oper Res 1983;31:1109-1144.
46. Raftery AE, Lewis SM. Comment: One long run with diagnostics: implementationstrategies for Markov chain Monte Carlo. Stat Sci 1992;7:493-497.
47. Bai G, Gajer P, Nandy M, et al. Comparison of storage conditions forhuman vaginal microbiome studies. PLoS ONE 2012;7:e36934.
48. Legendre P, Anderson MJ. Distance-based redundancy analysis: testingmultispecies responses in multifactorial ecological experiments. EcolMonogr 1999;69:1-24.
49. Plummer M, Best N, Cowles K, Vines K. CODA: convergence diagnosisand output analysis for MCMC. R News 2006;6:7-11.
50. Martin AD, Quinn KM, Park JH. MCMCpack: Markov chain MonteCarlo in R. J Stat Softw 2011;42:1-21.
51. Imai K, King G, Lau O. Zelig: everyone's statistical software. 2006. Availableat: http://projects.iq.harvard.edu/zelig. Accessed August 13, 2013.
52. Biagi E, Candela M, Franceschi C, Brigidi P. The aging gut microbiota:new perspectives. Ageing Res Rev 2011;10:428-429.
53. Kinross J, Nicholson JK. Gut microbiota: dietary and social modulationof gut microbiota in the elderly. Nat Rev Gastroenterol Hepatol 2012;9:563-564.
54. Ferris MJ, Norori J, Zozaya-Hinchliffe M, Martin DH. Cultivation- independentanalysis of changes in bacterial vaginosis flora followingmetronidazole treatment. J Clin Microbiol 2007;45:1016-1018.
55. Rampersaud R, Planet PJ, Randis TM, et al. Inerolysin, a cholesteroldependentcytolysin produced by Lactobacillus iners. J Bacteriol2011;193:1034-1041.
56. Reid G. Probiotic and prebiotic applications for vaginal health. J AOACInt 2012;95:31-34.
57. Tankó LB, Christiansen C. An update on the antiestrogenic effect ofsmoking: a literature review with implications for researchers and practitioners.Menopause 2004;11:104-109.
58. Brotman RM, Ravel J, Gajer P, et al. Biomarkers of cigarette smokingand association with the vaginal microbiota. The International Society forSexually Transmitted Disease Research, 20th Biennial Congress, Vienna,Austria 2013.
59. Fuchs EJ, Lee LA, Torbenson MS, et al. Hyperosmolar sexual lubricantcauses epithelial damage in the distal colon: potential implication for HIVtransmission. J Infect Dis 2007;195:703-710.
60. Burton JP, Reid G. Evaluation of the bacterial vaginal flora of 20 postmenopausalwomen by direct (Nugent score) and molecular (polymerasechain reaction and denaturing gradient gel electrophoresis) techniques.J Infect Dis 2002;186:1770-1780.
61. Heinemann C, Reid G. Vaginal microbial diversity among postmenopausalwomen with and without hormone replacement therapy. Can JMicrobiol 2005;51:777-781.
62. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectivenessof live lactobacilli in combination with low dose oestriol(Gynoflor) to restore the vaginal flora after treatment of vaginal infections.BJOG 2005;112:234-240.
63. Hillier SL, Lau RJ. Vaginal microflora in postmenopausal women whohave not received estrogen replacement therapy. Clin Infect Dis 1997;25(suppl 2):S123-S126.
64. Pabich WL, Fihn SD, Stamm WE. Prevalence and determinants of vaginalflora alterations in postmenopausal women. J Infect Dis 2003;188:1054-1058.
65. Burton JP, Devillard E, Cadieux PA, Hammond JA, Reid G. Detection ofAtopobium vaginae in postmenopausal women by cultivationindependentmethods warrants further investigation. J Clin Microbiol2004;42:1829-1831.
66. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, SalembierG, Spitz B. Definition of a type of abnormal vaginal flora that is distinctfrom bacterial vaginosis: aerobic vaginitis. BJOG 2002;109:34-43.